Previous studies have shown that cyclooxygenase-2 (COX-2) expression is enhanced in various solid tumors, including breast, lung and colorectal cancer, and is closely associated with tumor proliferation, invasion and metastasis, and thus, COX-2 is considered a promising target in antitumor gene therapy (1,2). The gene discussed is PTGS2; the disease is colorectal cancer.